GB201206192D0 - Ketone bodies and ketone body esters and for maintaining or improving muscle power output - Google Patents

Ketone bodies and ketone body esters and for maintaining or improving muscle power output

Info

Publication number
GB201206192D0
GB201206192D0 GBGB1206192.5A GB201206192A GB201206192D0 GB 201206192 D0 GB201206192 D0 GB 201206192D0 GB 201206192 A GB201206192 A GB 201206192A GB 201206192 D0 GB201206192 D0 GB 201206192D0
Authority
GB
United Kingdom
Prior art keywords
ketone
maintaining
power output
muscle power
improving muscle
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1206192.5A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tdeltas Ltd
Original Assignee
Tdeltas Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tdeltas Ltd filed Critical Tdeltas Ltd
Priority to GBGB1206192.5A priority Critical patent/GB201206192D0/en
Publication of GB201206192D0 publication Critical patent/GB201206192D0/en
Priority to JP2015503897A priority patent/JP6241956B2/ja
Priority to HK15107731.2A priority patent/HK1206999B/en
Priority to PCT/EP2013/057250 priority patent/WO2013150153A1/en
Priority to SG11201406343PA priority patent/SG11201406343PA/en
Priority to US14/390,495 priority patent/US20150164855A1/en
Priority to CA2873092A priority patent/CA2873092C/en
Priority to AU2013244931A priority patent/AU2013244931B2/en
Priority to ES13718524T priority patent/ES2748050T3/es
Priority to EP13718524.5A priority patent/EP2833882B1/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/225—Polycarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
GBGB1206192.5A 2012-04-05 2012-04-05 Ketone bodies and ketone body esters and for maintaining or improving muscle power output Ceased GB201206192D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB1206192.5A GB201206192D0 (en) 2012-04-05 2012-04-05 Ketone bodies and ketone body esters and for maintaining or improving muscle power output
EP13718524.5A EP2833882B1 (en) 2012-04-05 2013-04-05 Ketone bodies and ketone body esters for maintaining or improving muscle power output
SG11201406343PA SG11201406343PA (en) 2012-04-05 2013-04-05 Ketone bodies and ketone body esters for maintaining or improving muscle power output
HK15107731.2A HK1206999B (en) 2012-04-05 2013-04-05 Ketone bodies and ketone body esters for maintaining or improving muscle power output
PCT/EP2013/057250 WO2013150153A1 (en) 2012-04-05 2013-04-05 Ketone bodies and ketone body esters for maintaining or improving muscle power output
JP2015503897A JP6241956B2 (ja) 2012-04-05 2013-04-05 筋パワー出力を維持又は改善するためのケトン体及びケトン体エステル
US14/390,495 US20150164855A1 (en) 2012-04-05 2013-04-05 Ketone bodies and ketone body esters for maintaining or improving muscle power output
CA2873092A CA2873092C (en) 2012-04-05 2013-04-05 Ketone bodies and ketone body esters for maintaining or improving muscle power output
AU2013244931A AU2013244931B2 (en) 2012-04-05 2013-04-05 Ketone bodies and ketone body esters for maintaining or improving muscle power output
ES13718524T ES2748050T3 (es) 2012-04-05 2013-04-05 Cuerpos cetónicos y esteres de cuerpos cetónicos para mantener o mejorar la potencia muscular disponible

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1206192.5A GB201206192D0 (en) 2012-04-05 2012-04-05 Ketone bodies and ketone body esters and for maintaining or improving muscle power output

Publications (1)

Publication Number Publication Date
GB201206192D0 true GB201206192D0 (en) 2012-05-23

Family

ID=46176983

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1206192.5A Ceased GB201206192D0 (en) 2012-04-05 2012-04-05 Ketone bodies and ketone body esters and for maintaining or improving muscle power output

Country Status (9)

Country Link
US (1) US20150164855A1 (https=)
EP (1) EP2833882B1 (https=)
JP (1) JP6241956B2 (https=)
AU (1) AU2013244931B2 (https=)
CA (1) CA2873092C (https=)
ES (1) ES2748050T3 (https=)
GB (1) GB201206192D0 (https=)
SG (1) SG11201406343PA (https=)
WO (1) WO2013150153A1 (https=)

Families Citing this family (70)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1648952B1 (en) 2003-06-03 2018-03-07 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
DK2240017T3 (da) 2008-01-04 2019-06-17 Univ Oxford Innovation Ltd Ketonlegemer og ketonlegemsestere som blodlipid-sænkende midler
US8642654B2 (en) 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
GB201002983D0 (en) 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition
EP2914251B1 (en) 2012-11-05 2019-08-21 The United States of America, as represented by The Secretary, Department of Health and Human Services Ketone bodies to protect tissues from damage by ionizing radiation
GB201304467D0 (en) 2013-03-12 2013-04-24 Tdeltas Ltd Compound for use in protecting skin
SG11201507685UA (en) 2013-03-14 2015-10-29 Isis Innovation Process for producing (r)-3-hydroxybutyl (r)-3-hydroxybutyrate
KR102499654B1 (ko) 2013-03-19 2023-02-13 유니버시티 오브 사우스 플로리다 상승되고 지속되는 케톤증을 생성하기 위한 조성물 및 방법
GB201314127D0 (en) * 2013-08-07 2013-09-18 Tdeltas Ltd Ketone body and ketone body ester for reducing muscle breakdown
JP2015141458A (ja) * 2014-01-27 2015-08-03 株式会社タニタ ダイエット支援装置、方法、及びプログラム
WO2016012657A1 (en) * 2014-07-21 2016-01-28 Oulun Yliopisto Oligomeric forms of 3-hydroxybutyrate
US10245243B1 (en) * 2017-12-19 2019-04-02 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the S-enantiomer and methods of use
US10736861B2 (en) 2016-03-11 2020-08-11 Axcess Global Sciences, Llc Mixed salt compositions for producing elevated and sustained ketosis
US11185518B2 (en) 2017-12-19 2021-11-30 Axcess Global Sciences, Llc S-beta-hydroxybutyrate compounds and compositions enriched with S-enantiomer
US11103470B2 (en) 2017-11-22 2021-08-31 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US10245242B1 (en) * 2017-11-22 2019-04-02 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
US11241403B2 (en) 2016-03-11 2022-02-08 Axcess Global Sciences, Llc Beta-hydroxybutyrate mixed salt compositions and methods of use
US10973786B2 (en) 2016-03-11 2021-04-13 Axcess Global Sciences, Llc R-beta-hydroxybutyrate, S-beta-hydroxybutyrate, and RS-beta-hydroxybutyrate mixed salt compositions
US10973792B2 (en) 2019-02-13 2021-04-13 Axcess Global Sciences, Llc Racemic beta-hydroxybutyrate mixed salt-acid compositions and methods of use
WO2017165445A1 (en) * 2016-03-21 2017-09-28 Csilla Ari D'agostino Administration of exogenous ketone to lower blood glucose
US12533346B2 (en) 2016-04-19 2026-01-27 Axcess Global Sciences, Llc Administration of berberine metabolites
US12109182B2 (en) 2016-04-19 2024-10-08 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US12329734B2 (en) 2017-12-19 2025-06-17 Axcess Global Sciences, Llc Use of S-beta-hydroxybutyrate compounds for induction and maintenance of flow
US11202769B2 (en) 2017-11-22 2021-12-21 Axcess Global Sciences, Llc Ketone body esters of s-beta-hydroxybutyrate and/or s-1,3-butanediol for modifying metabolic function
US12521378B2 (en) 2016-04-19 2026-01-13 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate salt blend and related compounds in humans
US11806324B2 (en) 2018-04-18 2023-11-07 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for oral delivery of ketone bodies
US10925843B2 (en) 2018-04-18 2021-02-23 Axcess Global Sciences, Llc Compositions and methods for keto stacking with beta-hydroxybutyrate and acetoacetate
US12496283B2 (en) 2016-04-19 2025-12-16 Axcess Global Sciences, Llc Administration of R-beta-hydroxybutyrate and related compounds in humans
US11944598B2 (en) 2017-12-19 2024-04-02 Axcess Global Sciences, Llc Compositions containing s-beta-hydroxybutyrate or non-racemic mixtures enriched with the s-enatiomer
US20230346721A1 (en) 2018-04-18 2023-11-02 Axcess Global Sciences, Llc Beta-hydroxybutyric acid compositions and methods for delivery of ketone bodies
US12599579B2 (en) 2016-04-19 2026-04-14 Axcess Global Sciences, Llc Compositions and compounds containing ketone bodies and/or ketone body precursors and one or more amino acids
US20180057846A1 (en) 2016-08-30 2018-03-01 KetoneAid Inc. Partially buffered free acid and/or ketone blend for rapid onset ketosis and metabolic therapy
EP3558280B1 (en) 2016-12-21 2023-06-07 Universitäts-kinderspital Beider Basel Migraine prevention and treatment
MX390420B (es) * 2016-12-23 2025-03-20 Univ Leuven Kath 3-hidroxibutirato solo o en combinación para su uso en el tratamiento de cuidados intensivos.
JP7763026B2 (ja) 2017-03-31 2025-10-31 ジェノマティカ， インコーポレイテッド アルデヒドデヒドロゲナーゼバリアントおよび使用の方法
JP2020512351A (ja) 2017-03-31 2020-04-23 ジェノマティカ， インコーポレイテッド 発酵ブロスから１，３−ブタンジオールを取得するためのプロセスおよびシステム
WO2018183640A1 (en) 2017-03-31 2018-10-04 Genomatica, Inc. 3-hydroxybutyryl-coa dehydrogenase variants and methods of use
US20190231742A1 (en) * 2017-04-20 2019-08-01 Theodore B. VANITALLIE Nutritional agents used to prevent and treat hypersensitivity and other allergic-type disorders
GB201710229D0 (en) * 2017-06-27 2017-08-09 Tdeltas Ltd Compounds for new use
US11760963B2 (en) 2017-08-23 2023-09-19 KetoneAid Inc. Ketogenic beer and alcoholic beverage mixture containing non-racemic ethyl 3-hydroxybutyrate and/or 1,3 butanediol
GB201715654D0 (en) 2017-09-27 2017-11-08 Tdeltas Ltd Method of treatment
US12090129B2 (en) 2017-11-22 2024-09-17 Axcess Global Sciences, Llc Non-racemic beta-hydroxybutyrate compounds and compositions enriched with the R-enantiomer and methods of use
AU2019239096A1 (en) * 2018-03-23 2020-08-27 Concert Pharmaceuticals, Inc. Deuterated analogs of D-beta-hydroxybutyric acid and uses thereof
US11241401B2 (en) 2020-02-06 2022-02-08 Axcess Global Sciences, Llc Enantiomerically pure r-beta-hydroxybutyrate mixed salt-acid compositions
US11419836B2 (en) 2019-02-13 2022-08-23 Axcess Global Sciences, Llc Racemic and near racemic beta-hydroxybutyrate mixed salt-acid compositions
US11129802B2 (en) 2018-08-27 2021-09-28 Axcess Global Sciences, Llc Compositions and methods for delivering cannabidiol and ketone bodies
US10980772B2 (en) 2018-08-27 2021-04-20 Axcess Global Sciences, Llc Compositions and methods for delivering tetrahydrocannabinol and ketone bodies
GB2575623B (en) * 2018-06-04 2022-10-26 Tdeltas Ltd 3-hydroxybutyrate esters for treating cancer cachexia
EP3856896A1 (en) 2018-09-26 2021-08-04 Genomatica, Inc. Aldehyde dehydrogenase variants and methods of using same
GB2577723A (en) * 2018-10-04 2020-04-08 Tdeltas Ltd Compounds for new use
BR112021014012A2 (pt) * 2019-01-17 2021-09-21 Ioi Oleo Gmbh Processo para a produção de lipídeos que contêm unidades estruturais com base em glicerídeos de ácidos hidroxicarboxílicos
WO2020147983A1 (de) * 2019-01-17 2020-07-23 Ioi Oleo Gmbh Verfahren zur herstellung von polyolbasierten estern von gegebenenfalls acylierten hydroxycarbonsäuren
WO2020147979A1 (de) * 2019-01-17 2020-07-23 Ioi Oleo Gmbh Verfahren zur herstellung von polyolbasierten estern von hydroxycarbonsäuren
ES2941943T3 (es) * 2019-01-17 2023-05-26 Ketolipix Therapeutics Gmbh Método para la producción de glicéridos de ácidos hidroxicarboxílicos
BR112021017954A2 (pt) * 2019-03-14 2021-11-16 Neuroenergy Ventures Inc Formulação de mascaramento de sabor para compostos de corpo cetônico
US12472200B2 (en) 2019-05-15 2025-11-18 Axcess Global Sciences, Llc Autobiotic compositions and method for promoting healthy gut microbiome
CN114008014B (zh) * 2019-06-12 2024-03-22 凯托利皮克斯治疗有限责任公司 用于生产酰基封端的3-羟基羧酸的多元醇基酯的方法
US20230020342A1 (en) * 2019-06-12 2023-01-19 Ioi Oleo Gmbh Method for producing polyol-based esters, in particular polyglycerol esters, from hydroxy carboxylic acids
US11033553B2 (en) 2019-06-21 2021-06-15 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US11969430B1 (en) 2023-03-10 2024-04-30 Axcess Global Sciences, Llc Compositions containing paraxanthine and beta-hydroxybutyrate or precursor for increasing neurological and physiological performance
US11950616B2 (en) 2019-06-21 2024-04-09 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
US12167993B2 (en) 2019-06-21 2024-12-17 Axcess Global Sciences, Llc Non-vasoconstricting energy-promoting compositions containing ketone bodies
WO2021178547A1 (en) 2020-03-05 2021-09-10 Devon Price COMPOSITION OF (D)-β-HYDROXYBUTYRIC ACID, (D)-β-HYDROXYVALERIC ACID, AND (D)-1,3 BUTANEDIOL AS A NUTRITIONAL SUPPLEMENT AND THERAPEUTIC AGENT
WO2021195477A1 (en) 2020-03-27 2021-09-30 Ketoneaid, Inc. Ketone ester as a therapeutic treatment of covid-19, long covid, and related viral infections
JP7737231B2 (ja) * 2020-03-31 2025-09-10 大阪瓦斯株式会社 ジオール化合物およびその重合体ならびにそれらの製造方法
US12186297B2 (en) 2020-08-26 2025-01-07 Axcess Global Sciences, Llc Compositions and methods for increasing lean-to-fat mass ratio
KR20240037239A (ko) 2021-07-17 2024-03-21 케토스위스 아게 케톤체 또는 케톤 생성 화합물과 진통제 또는 항산화제의 조합
MX2024005533A (es) * 2021-11-12 2024-07-29 Arxada Ag Compuestos derivados de polioles.
US11807600B2 (en) 2021-11-12 2023-11-07 Samuel J. Rozzoni Synthesis of novel ketone body analogs for use as a nutritional supplement
GB202219317D0 (en) * 2022-12-20 2023-02-01 Amazentis Sa Methods for improving mitophagy in subjects

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995009144A1 (en) * 1993-09-30 1995-04-06 Eastman Chemical Company Nutritive water soluble glycerol esters of hydroxy butyric acid
JP4598203B2 (ja) 1995-12-01 2010-12-15 ビーティージー・インターナショナル・リミテッド 脳機能改善剤
ES2574918T3 (es) 2003-06-02 2016-06-23 Isis Innovation Limited Tratamiento de la fatiga muscular
EP1648952B1 (en) * 2003-06-03 2018-03-07 THE UNITED STATES GOVERNMENT as represented by THE DEPARTMENT OF HEALTH AND HUMAN SERVICES Nutritional supplements and therapeutic compositions comprising (r)-3-hydroxybutyrate derivatives
US7117715B2 (en) * 2004-07-09 2006-10-10 Owens-Brockway Glass Container Inc. Servo mechanism test stand
EP1778213B1 (en) * 2004-07-16 2017-04-05 BTG International Limited A method for the synthesis of oligomeric compounds
EP3296284B1 (en) * 2008-08-21 2021-12-01 The Government of the United States of America, as repres. by the Secretary of Health and Human Services, Nat. Inst. of Health Non-therapeutical use of hydroxybutyrate ester
US8642654B2 (en) * 2009-04-16 2014-02-04 Isis Innovation Limited Hydroxybutyrate ester and medical use thereof
GB201002983D0 (en) * 2010-02-22 2010-04-07 Tdeltas Ltd Nutritinal composition

Also Published As

Publication number Publication date
JP2015514104A (ja) 2015-05-18
CA2873092C (en) 2020-08-04
ES2748050T3 (es) 2020-03-12
US20150164855A1 (en) 2015-06-18
WO2013150153A1 (en) 2013-10-10
CA2873092A1 (en) 2013-10-10
SG11201406343PA (en) 2014-11-27
EP2833882B1 (en) 2019-07-24
EP2833882A1 (en) 2015-02-11
HK1206999A1 (en) 2016-01-22
AU2013244931A1 (en) 2014-11-20
AU2013244931B2 (en) 2018-01-18
JP6241956B2 (ja) 2017-12-06

Similar Documents

Publication Publication Date Title
SG11201406343PA (en) Ketone bodies and ketone body esters for maintaining or improving muscle power output
GB2517088B (en) Ketone body and ketone body ester for reducing muscle breakdown
GB2500915B (en) Arrangement and method
IL225246A0 (en) Methods for speeding up the restoration of skin normality and for treatment of impetigo
GB201215962D0 (en) Power tailgate system and method
IL233674B (en) Preparations and methods for using phorbol esters for stroke treatment
GB201218862D0 (en) Bicyclic heterocycle compounds and their uses in therapy
AP2014008172A0 (en) Nanocomposite and method of making the same
HUE042637T2 (hu) Laminátumok és azok elõállítására szolgáló módszerek
GB201218850D0 (en) Bicyclic heterocycle compounds and their uses in therapy
GB201218864D0 (en) Bicyclic heterocycle compounds and their uses in therapy
EP2631068A4 (en) LAMINATED BODY AND MANUFACTURING METHOD THEREOF
GB2508041B (en) Rack and power control method thereof
GB201218831D0 (en) Permenter and the method of fermentation
EP2857289A4 (en) STRUCTURAL BODY OF A SHOCK CABINET AND MANUFACTURING METHOD FOR STRUCTURAL BODY OF A SHOCK CABINET
IL238274A0 (en) Methods and preparations for local increase of body fat
ZA201408056B (en) Compositions and methods for the treatment of mucositis
PL2919736T3 (pl) Wyroby chłonne obejmujące laminat i sposoby ich wytwarzania
AU343512S (en) Human model
EP2849712A4 (en) METHOD AND DEVICES FOR PROVIDING MECHANICAL STIMULATION TO A BODY
GB2510238B8 (en) Power converter and its control method
ZA201405932B (en) Energy plant and parts of an energy plant
EP2931140A4 (en) Tissue repair equipment and methods
SG11201503663SA (en) Settling tank and method of operating the same
ZA201500547B (en) Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)